3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Promyelocytic, Acute
20
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
9
Multiple Myeloma
9
Leukemia
8
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Uterine Cervical Neoplasms
3
Neuroblastoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Thrombocytopenia
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Interventions
Cisplatin
43
Radiotherapy
27
Radiotherapy, Intensity-Modulated
24
Radiation
16
Carboplatin
14
Surveys and Questionnaires
13
Magnetic Resonance Spectroscopy
13
Cetuximab
11
Surgical Procedures, Operative
10
pembrolizumab
9
Specimen Handling
8
Chemoradiotherapy
8
Drug Therapy
7
Docetaxel
7
Biopsy
7
1,2-diaminocyclohexaneplatinum II citrate
7
Platinum
6
Paclitaxel
6
Fluorouracil
6
durvalumab
5
X-Rays
5
Observation
5
Blood Specimen Collection
5
Standard of Care
4
Nivolumab
4
Immunohistochemistry
4
Celecoxib
4
Taxes
3
Neck Dissection
3
Liquid Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Oropharyngeal Neoplasms
×
Tretinoin
×
Clear all
NCT06706401
2026-04-24
LYSARI
Centre Leon Berard
Phase 3
Recruiting
460 enrolled